Partners4Access collaborates with Cambridge University

          Partners4Access, the global access experts for orphan drugs, has entered into a collaboration with Cambridge University to support their Graduate Professional Practice Programme.  Partners4Access will support a student from the Masters in Bioscience Enterprise program develop their dissertation, providing a platform to engage in a corporate-level environment.  Sophie Schmitz, Managing Partner at Partners4Access said,…

Hot topics in pharma and orphan drugs

I attended this year’s pharma pricing and market access conference in London with attendees across the pharmaceutical industry, payer and HTA bodies and patient representatives. While following the talks, panel discussions and roundtable debates, a few overarching key topics crystallised: –          Germany – AMNOG changes AMNOG, the German pharmaceutical law is regularly adapted to changes…

Partners4Access represented at ISPOR

Partners4Access was part of this year’s ISPOR conference in Vienna where payers, manufacturers, regulators and politicians met. High profile speakers from national, regional and global bodies discussed different pricing models for pharmaceuticals, their feasibility and importance to create sustainable and fair health systems. Striving towards a fair health system is closely linked to another key…